# Nurix Therapeutics, Inc.: Form 8-K, filed Dec 11, 2023

- Company: [Nurix Therapeutics, Inc.](/companies/nrix.md) (CIK 1549595)
- Form: 8-K
- Filed: 2023-12-11
- Accepted by EDGAR: Dec 11, 2023, 12:03 ET
- Period: 2023-12-11
- Accession: 0001549595-23-000062
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1549595/000154959523000062/nrix-20231211.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1549595/000154959523000062/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1549595/000154959523000062/nrix-20231211.htm

Filed Dec 11, 2023.
Source: SEC EDGAR, the filing index for accession 0001549595-23-000062. Last ingested by Listed: Nov 5, 2026, 13:59 ET. No prices; not investment advice.